CORRECTION: Mesa Laboratories Q1 2025 EPS $0.62 Beats $0.44 Estimate, Sales $58.17M Beat $55.74M Estimate
Portfolio Pulse from Benzinga Newsdesk
Mesa Laboratories (NASDAQ:MLAB) reported Q1 2025 adjusted EPS of $0.62, beating the $0.44 estimate by 40.91%. Sales were $58.17M, surpassing the $55.74M estimate by 4.35% and marking a 14.86% increase from the same period last year.
August 05, 2024 | 12:55 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mesa Laboratories reported strong Q1 2025 earnings with an adjusted EPS of $0.62, beating estimates by 40.91%. Sales also exceeded expectations, growing 14.86% year-over-year.
The significant beat on both EPS and sales estimates, along with strong year-over-year growth, is likely to positively impact MLAB's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100